Fulgent Genetics, Inc. (FLGT) Tops Q1 EPS by 12c ; Offers Guidance

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $73.5 million versus the consensus estimate of $73.89 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2025 EPS of ~($0.65), versus the consensus of ($0.66). Fulgent Genetics, Inc. sees FY2025 revenue of ~$310 million, versus the consensus of $310.4 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance